超大化学空间的基于结构的虚拟选:进步和陷
François Sindt1, Didier Rognan1
1Laboratoire d'innovation Thérapeutique, UMR7200 CNRS-Université de Strasbourg, Illkirch, 67400, France.
European journal of medicinal chemistry
|January 15, 2026
概括
计算化学家探索超大化学空间,包含数万亿个分子,用于药物发现. 创新的算法对于有效选和识别强效药物候选人至关重要,克服了庞大的分子多样性的挑战.
科学领域:
- 计算化学是一种计算化学.
- 药品化学 药品化学 是一个
- 药物发现 药物发现
背景情况:
- 按需的化学空间提供了从商业建筑块中容易合成的分子.
- 这些化学空间的规模已经扩大到数万亿种化合物.
- 需要高效的算法来编目,存储和虚拟选,特别是3D蛋白质目标.
研究的目的:
- 审查基于结构的超大虚拟选的主要方法.
- 突出大规模查的优势和挑战.
- 讨论超大化学空间对早期药物发现的影响.
主要方法:
- 检查当前基于结构的超大虚拟选方法.
- 分析潜在的应用程序及其依赖于粗暴强力对接的情况.
- 审查最近的发展,整合主动学习,概率抽样和synthon引导方法.
主要成果:
- 选超大化学空间可以获得更好的命中率和更强大的命中.
- 化学空间的指数增长带来了重大的实际和理论障碍.
- 新的方法加速对接,并有效地优先考虑有前途的化合物.
结论:
- 超大化学空间为药物发现中的早期发现提供了变革性的潜力.
- 集成先进的算法对于管理和利用这些庞大的分子资源至关重要.
- 早期药物发现的组织正在被超大化学空间的可用性所重塑.
相关概念视频
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K


